| 11:30 AM | TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI Lecturer: Hanbit Park |
| 11:35 AM | ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR Lecturer: Jinho Lee |
| 11:40 AM | DEFINE-DM Trial: Imaging- and Physiology-guided State-of-the Art PCI vs. CABG for DM and Multi-Vessel Disease Lecturer: Hoyun Kim |
| 11:45 AM | FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI Lecturer: Jung-Min Ahn |
| 11:50 AM | Panel Discussion l |
| 12:05 PM | EPIC-CAD Trial: Long-Term Antithrombotic Strategy in AF Patients With Stable CAD Lecturer: Gi-Byoung Nam |
| 12:10 PM | PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI Lecturer: Jinho Lee |
| 12:15 PM | ASSURE-DES Trial: Optimal Antiplatelet Strategy in DES Patients During Noncardiac Surgery Lecturer: Hanbit Park |
| 12:20 PM | VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD Lecturer: Jung-Min Ahn |
| 12:25 PM | Panel Discussion ll |